Archive - The World In A Grain of Sand by KdT Ventures

Podcast: Verve Therapeutics

Ketan Yerneni and Mack Healy dig into a gene editing biotech tackling one of the most prevalent chronic diseases.

Feb 22 •

,

, and

September 2023

Podcast: Schrödinger

A deep dive into the science and business of the OG AI-driven drug discovery company

Sep 6, 2023 •

and

August 2023

Who I am: Blair

As a firm, the team at KdT has decided to publish long-form biographies to help the folks we work with learn more about who we are as people. Our hope…

Aug 9, 2023 •

July 2023

Who I am: Yusuf

As a firm, the team at KdT has decided to publish long-form biographies to help the folks we work with learn more about who we are as people. Our hope…

Jul 24, 2023 •

Who I am: Patrick

As a firm, the team at KdT has decided to publish long-form biographies to help the folks we work with learn more about who we are as people. Our hope…

Jul 17, 2023 •

April 2023

Podcast: Amylyx Pharmaceuticals

a neuro biotech founded in the dorm room of two scrappy Brown undergrads

Apr 19, 2023 •

Rima Chakrabarti

,

, and

March 2023

Overscienced but Underfunded: Research Triangle, NC (Durham, Raleigh, Chapel Hill)

Impactful science and technology can be invented anywhere

Mar 29, 2023 •

,

,

,

Anirudh Sudarshan

, and

Dalton Hughes, PhD

September 2022

Expanding the Drug Delivery Toolbox

Today our ability to treat many diseases is limited only by our ability to effectively deliver genetic medicines. Patients treated with genetic…

Sep 15, 2022

May 2022

State of the Market: The Goalposts

Before I start, let me get two things out of the way. First, in no way am I the caller of market tops and bottoms — and that’s not the intent of this…

May 9, 2022

The Bioproduction Battle

The globalization that began during the 1990s and flourished into this millennia reshaped aspects of our lives in ways we are only now appreciating…

May 2, 2022 •

Anirudh Sudarshan

and

February 2022

How health insurance DAOs can break up RWD silos

KdT has recently been exploring alternative data sharing incentive structures, since as a firm we believe the greatest advancements in science and…

Feb 14, 2022

August 2021

Zymergen: A Cautionary Tale

As we continue to digest the news from Zymergen and its reverberations across the Synthetic Biology ecosystem, we wanted to take a moment to reflect in…

Aug 5, 2021

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts